Vanguard Group Inc Atri Cure, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,653,205 shares of ATRC stock, worth $162 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,653,205
Previous 4,659,781
0.14%
Holding current value
$162 Million
Previous $131 Million
8.83%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ATRC
# of Institutions
228Shares Held
46.4MCall Options Held
25.8KPut Options Held
4.5K-
Black Rock Inc. New York, NY4.62MShares$161 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.84MShares$134 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.92MShares$102 Million1.54% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.53MShares$88.1 Million0.51% of portfolio
-
Macquarie Group LTD Australia, C32.38MShares$82.8 Million0.08% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.62B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...